Investing in Clinuvel (6)

Clinuvel is a publicly listed company on the ASX (CUV), Xetra-Dax (UR9) and a Level 1 ADR (CLVLY). In this section, Shareholders are able to link through to the company's share registry, Computershare, and perform the following tasks: View Your Security Holdings Account DetailsBalancesCommunication Details Change your Share Holdings Records Click here to go to the Computershare website. To subscribe to Clinuvel's email database click here.

Clinuvel is listed on the Australian Securities Exchange under the ticker code CUV.   Share price and chart provided by Iguana2 International listings Clinuvel stock is available in the USA as a level 1 ADR (CLVLY) through the Bank of New York Mellon with the symbol CLVLY. Click here for the CLVLY price (third party site). Clinuvel stock is available in Europe through the Xetra listing UR9. Click here for the UR9 price (third party site). Clinuvel does not issue stock directly to investors. Please contact a financial advisor for…

Clinuvel Pharmaceuticals is a publicly listed company. The company’s stock can be purchased through two different listing or via an ADR program in the US. Clinuvel does not issue stock directly to investors. The company’s primary listing is with the Australian Securities Exchange (ASX) under the ticker code CUV. The ASX maintains an extensive education program on its website to help potential investors understand the stock market and ASX listed companies. For more information, log onto the ASX Education website. Clinuvel’s ASX register is maintained by Computershare. Through the Computershare…

ASX shareholders Clinuvel maintains its ASX shareholder registry with Computershare. For all enquiries related to your shareholding, contact: The RegistrarComputershare Investor Services Pty LimitedGPO Box 2975Australia(Aus) 1300 555 159(International) +61 (0)3 9415 4062 Shareholders are able to access the company's share registry with Computershare online and perform the following tasks: View Your Security Holdings Account Details Balances Communication Details Change your Shareholdings Records Click here to go to the Computershare website. American Depository Receipts holders Clinuvel's stock is available as an ADR through the Bank of New York Mellon under…

Clinuvel has raised over A$66million since 2006 to fund its clinical program for afamelanotide. The company has forecast that its current cash reserves are sufficient to fund afamelanotide to its first Marketing Authorisation Application. Latest Quarterly Report (Appendix 4C) Latest Quarterly Report (Appendix 4C)Q1 2012 - Calender Year Cash and financial assets at end of Quarter A$ 9.289 million Average operating cash outflows (Jan 1 - Mar 31 2012) A$ 0.86 million per month Average net operating cash flows (Jan 1 - Mar 31 2012) A$ 0.81 million per month…